UT-15C SR in the Treatment of Critical Limb Ischemia
NCT00445159
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Critical Limb Ischemia
Interventions
DRUG:
UT-15C SR (treprostinil diethanolamine) 1mg oral tablets
Sponsor
Southern Arizona Vascular Institute
Collaborators
[object Object]